US Stock MarketDetailed Quotes
GYRE Gyre Therapeutics
- 13.680
- -0.160-1.16%
Trading Nov 15 11:38 ET
1.17BMarket Cap-9369P/E (TTM)
13.800High12.651Low42.34KVolume13.800Open13.840Pre Close554.32KTurnover0.26%Turnover RatioLossP/E (Static)85.82MShares30.40052wk High18.59P/B219.31MFloat Cap8.26052wk Low--Dividend TTM16.03MShs Float5798.166Historical High--Div YieldTTM8.31%Amplitude0.854Historical Low13.092Avg Price1Lot Size
Gyre Therapeutics Key Stats
EPS
According to the latest financial report of Gyre Therapeutics, the latest earnings per share (TTM) for the company is 0.01. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Gyre Therapeutics's free cash flow? The latest report shows it as -6.95M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Gyre Therapeutics shows that the company's current ratio is 3.44, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Gyre Therapeutics, the quick ratio is 2.89, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Gyre Therapeutics? The latest ROE figure is 6.03%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Gyre Therapeutics, the total asset return on investment (ROA) is 2.90%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Gyre Therapeutics's latest financial report to see how their gross margin is doing - currently at 96.95%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Gyre Therapeutics, the net profit margin is 17.99%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data